Nimodipine: Clinical Trials

34 trials of Nimodipine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 4 unknown, 3 recruiting, 3 terminated. 10 Phase 2, 7 Phase 4, 5 Not applicable, 5 Phase 1, 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Completed 5, Not yet recruiting 2, Withdrawn 2, Terminated 1
Phase 47Completed 2, Recruiting 1, Suspended 1, Terminated 1, Unknown 1, Withdrawn 1
Not applicable5Completed 2, Recruiting 2, Terminated 1
Phase 15Completed 5
Early Phase 13Active not recruiting 1, Completed 1, Unknown 1
Phase 32Active not recruiting 1, Completed 1

Follow Nimodipine: new trials by email Literature Review of Nimodipine trials Research Report on Nimodipine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Nimodipine on Alcohol Drinking
Nimodipine, Placebo - Alcohol Use Disorder
Phase 2Not yet recruitingYale University402026-09-012026-07-02
Pilot Study: Effects of Nimodipine on Alcohol Drinking
Nimodipine - Alcohol Use Disorder
Phase 2Not yet recruitingYale University52026-09-012026-03-17
NICardipine for Fast Achievement of Systolic BP Targets in ICH
Nicardipine, Glyceryl trinitrate - Intracerebral Haemorrhage
Phase 4RecruitingAarhus University Hospital882025-10-012026-06-24
Perioperative Intravenous Nimodipine Trial
Nimodipine, Isotonic Saline - Colectomy, Open Surgery
Not applicableRecruitingUniversity of Ioannina402025-05-192026-09-14
A Causal Role for Voltage-gated Cav1.2 Calcium Channels in Mediating 5G FR1 Effects on Sleep-associated Brain Health in Humans
Nimodipine Capsules, 5G RF-EMF - Mediation of 5G Effects on Sleep
Not applicableRecruitingHans-Peter Landolt302024-10-222025-05-31
Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH
GTX-104, Nimotop 30 MG Oral Capsule - Aneurysmal Subarachnoid Hemorrhage (aSAH)
Phase 3Active not recruitingGrace Therapeutics Inc.1002023-10-202024-10-01
Management of Cerebral Vascular Spasm in Posttraumatic Subarachnoid Hemorrhage Using Combination Therapy
nimodipine, Oral Nimodipine and milrinone - Oral Nimodipine, Milrinone
Phase 2CompletedZagazig University302021-11-242022-05-25
Relative Bioavailability of Intravenous GTX-104 Compared to Oral Nimodipine Capsules in Healthy Subjects
GTX-104, Nimodipine Capsules - Aneurysmal Subarachnoid Hemorrhage
Phase 1CompletedGrace Therapeutics Inc.582021-08-262023-08-31
Pharmacological Mechanisms of Low-intensity Focused Ultrasound for Motor Cortex Neuroplasticity
Carbamazepine, Lorazepam, Dextromethorphan - Low Intensity Focussed Ultrasound
Early Phase 1Active not recruitingUniversity Health Network, Toronto202021-05-252025-08-03
Cerebral Nimodipine Concentrations Following Oral, Intra-venous and Intra-arterial Administration
Nimodipine - Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia
UnknownMedical University of Vienna302020-11-252023-10-19
Effectiveness of Calcium Channel Blockade for OP and Carbamate Pesticide Poisoning
Magnesium Sulfate, Nimodipine - Anticholinesterase Insecticide Poisoning, Pesticide Poisoning
Phase 3CompletedUniversity of Edinburgh17282020-06-112025-10-01
Coronavirus (COVID-19) ACEi/ARB Investigation
Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19
Phase 4SuspendedNational University of Ireland, Galway, Ireland24142020-04-302020-06-30
Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker
stellate ganglion block by transcranial doppler, Nimodipine - Subarachnoid Hemorrhage
Phase 2CompletedAssiut University402020-01-112023-06-13
Measuring Blood Flow in the Brain After Epileptic Activity
Paracetamol, Nimotop - Epilepsy, Depression
Phase 2CompletedRijnstate Hospital342019-12-052023-11-18
Cognitive Effects of Nimodipine in Patients With Schizophrenia
Nimodipine, Placebo oral capsule - Schizophrenia, Schizo Affective Disorder
Early Phase 1CompletedJohns Hopkins University182018-10-052023-06-23
Bioavailability Comparison Study of Two Types of Nimodipine Injections in Healthy Volunteers
Nimodipine Injection, Nimodipine Injection (II) - Bioavailability, Safety Issues
Early Phase 1UnknownShenyang Dongxing Pharmaceutical Technology Co., Ltd.262018-08-232019-01-08
RCVS: The Rational Approach to Diagnosis and Treatment
TCD- cerebral blood flow velocities, Headache pain score, Neurological examination - Reversible Cerebral Vasoconstriction Syndrome
Phase 4WithdrawnJohns Hopkins University2017-07-012019-09-18
Noninvasive Assessment of Cerebral Oxygenation and Cardiac Function in Patients With Neurovascular Diseases
Nimodipine - Subarachnoid Hemorrhage, Aneurysmal
CompletedNational Institute of Mental Health and Neuro Sciences, India252016-12-012019-03-26
The Effect of Nimodipine on the Postoperative Cognitive Dysfunction
Nimodipine group, Control group - Mild Cognitive Impairment
Not applicableTerminatedUniversity Hospital Hradec Kralove152015-09-012019-10-01
Carbonic Anhydrase Antagonism in Subarachnoid Hemorrhage
Acetazolamide, Nimodipine - Acute Cerebrovascular Accident, Vasospasm
Phase 2WithdrawnUniversity of Florida2015-09-012015-09-24

Showing 20 of 34. Sign in to see all of them.

Conditions studied

Subarachnoid Hemorrhage (8)  ·  Stroke (3)  ·  Alcoholism (2)  ·  Cocaine-Related Disorders (2)  ·  Cognitive Dysfunction (2)  ·  Depression (2)  ·  Hypertension (2)  ·  Vasospasm, Intracranial (2)  ·  AIDS Dementia Complex (1)  ·  AIDS-Related Complex (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Acute Pain (1)  ·  Anovulation (1)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)

Sponsors

Yale University (3)  ·  Grace Therapeutics Inc. (2)  ·  Johns Hopkins University (2)  ·  Aarhus University Hospital (1)  ·  Assiut University (1)  ·  Boston IVF (1)  ·  Edge Therapeutics Inc (1)  ·  FDA Office of Orphan Products Development (1)  ·  Fengtian Hospital (1)  ·  Hans-Peter Landolt (1)  ·  Janssen-Cilag Farmaceutica Ltda. (1)  ·  Medical University of Vienna (1)  ·  Ministry of Science and Technology of the PeopleĀ“s Republic of China (1)  ·  Mount Sinai Hospital, Canada (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (12)  ·  Canada (4)  ·  China (4)  ·  Czechia (2)  ·  Egypt (2)  ·  Austria (1)  ·  Bangladesh (1)  ·  Denmark (1)  ·  Finland (1)  ·  Greece (1)  ·  India (1)  ·  Ireland (1)  ·  Netherlands (1)  ·  Switzerland (1)

Top investigators

Suchitra Krishnan-Sarin (2)  ·  Adam Boxer, MD, PhD (1)  ·  Alan S Penzias, MD (1)  ·  Daniel Hanggi (1)  ·  Dr Fazle Rabbi Chowdhury, MD (1)  ·  Elisabeth B Marsh, MD (1)  ·  Ellen M. Whyte, MD (1)  ·  Eric Sicard, MD (1)  ·  Jeroen A van Waarde, MD (1)  ·  John William McEvoy, MBBCh MHS (1)  ·  Kristin Bigos, PhD (1)  ·  Lipton S (1)  ·  Michael Anthony Belfort (1)  ·  Navia B (1)

Results publications

PMID 24964105, PMID 25678453, PMID 27932607, PMID 31812149, PMID 35436940, PMID 36659633, PMID 39560199, PMID 39875683, PMID 40659830

NIH funding

P50AA012870 (2), K23MH067710 (1), P50DA009250 (1)